Mitre Medical

New Animation

Advancing cardiac surgery

Empowering surgeons

Image is not available

Placing innovation in the hands of your surgeon

Mitre Medical is an early stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR.

The clinical need and economic opportunity

Treating and preventing Heart Failure (HF) is the goal of the $10B structural heart market – growing to $20B by 2028. HF is characterized by a 10% enlargement of the left ventricle (LV) every year.

Empowering surgeons

Surgeons have used our Mitral Touch to reverse this deadly trend of HF enlargement by
directly reducing the LV >30%
in a beating heart without opening or stopping the heart.

Exceptional clinical Results

Using the Mitral Touch, surgeons have achieved
the greatest LV reduction ever published for a beating heart therapy.
 (Thourani et al., 2021)